A fundamental function of T helper (Th) cells is to regulate B-cell proliferation and immunoglobulin class switching, especially in the germinal centers. Th1 and Th2 lineages of CD4 1 T cells have long been considered to play an essential role in helping B cells by promoting the production immunoglobulin G2a (IgG2a) and IgG1/IgE, respectively. Recently, it has become clear that a subset CD4 1 T cells, named T follicular helper (Tfh) cells, is critical to B-cell response induction. In this review, we summarize the latest advances in our understanding of the regulation of Tfh cell differentiation, the relationship of Tfh cells to other CD4
INTRODUCTION

Upon encountering their cognate antigens on the surface of professional antigen-presenting cells (APCs), naive CD4
1 T helper (Th) cells differentiate into various effector subsets, such as Th1, Th2, Th17 or regulatory T (Treg) cells. Th cell fate depends on microenvironmental factors, including cytokine milieu (Figure 1 ). Each T-cell subset exerts its unique effector functions by migrating to its target anatomic location, which is mediated by the expression of relevant chemokine receptors and production of signature cytokines.
1- 4 The development of each of these Th cell subsets is driven by the following lineage-specific transcription factors: T-bet for Th1, GATA3 for Th2, retinoic acidrelated orphan receptor-a (RORa) and RORc for Th17, and Forkhead box p3 (Foxp3) for Treg cells (Figure 1 ). The help that T cells provide to B cells is a critical component of normal immune responses. Th1 and Th2 cell lineages are essential to the regulation of B-cell proliferation and immunoglobulin class switching. For example, the Th1 cytokine interferon-c (IFN-c) regulates immunoglobulin G2a (IgG2a) production, while the Th2 cytokine interleukin-4 (IL-4) is critical to IgG1/IgE class switching 5, 6 and transforming growth factor-b (TGF-b) and IL-10 are implicated in the switch to IgA. 7 A recent study also suggested that IL-17 drives autoimmune responses by promoting the spontaneous formation of germinal centers, implicating Th17 cells in the regulation of autoreactive antibodies. 8 Recently, it has been elucidated that a subset of CD4
1 T cells known as T follicular helper (Tfh) cells, named for their localization in germinal centers, are critical to germinal-center formation and function. In mice and humans, these cells are phenotypically different from other CD4
1 Th subsets. Differences include high-level expression of CXC receptor 5 (CXCR5), which leads to migration of Tfh cells to CXCL13-expressing B-cell follicles. 6 These cells are then thought to regulate humoral immunity and particularly germinal-center reactions.
Consistent with this notion, CXCR5 has been shown to be important for proper T-and B-cell localization in immune responses and during antibody production. 9, 10 Although activated T cells may transiently express CXCR5, Tfh cells exhibit more stable expression of this chemokine receptor. In addition to CXCR5, other Tfh cell markers have been also reported, such as the costimulatory receptor-inducible costimulatory molecule (ICOS), the cytokine IL-21 and the transcription factor B-cell lymphoma 6 (Bcl6). ICOS is essential for generation and maintenance of Tfh cells. 11 Meanwhile, IL-21 produced by Tfh cells directly regulates B-cell proliferation and class switching, and IL-21R deficiency results in inadequate antibody responses and impaired germinal-center formation. 12 Moreover, sanroque mice, which have a mutation in the RING-type E3 ubiquitin ligase Roquin, developed spontaneous autoantibody production and lupus-like autoimmunity, which is associated with greatly increased numbers of CXCR5 1 CD4 1 T cells and enhanced IL-21 and ICOS expression. 13 Despite the successful characterization of their surface markers and their potential importance in humoral immunity and immunopathology, the developmental regulation of Tfh cells is still being clarified.
Over the past 2 to 3 years, there has been rapid and exciting progress in our understanding of the developmental regulation of murine and human Tfh cells. In this review, we summarize the latest findings regarding the origin of these cells, their developmental regulation by cytokines and transcription factors, and their relationship to other effector CD4 1 T-cell subsets. Additionally, we review the function of Tfh cells in the progression of autoimmune responses.
IDENTIFICATION AND CHARACTERIZATION OF TFH CELLS
A fundamental function of Th cells is to provide help to B cells and to regulate their proliferation and immunoglobulin class switching, especially in the germinal centers. Follicle-associated CD4 1 T cells were first identified more than 20 years ago in the germinal centers of human tonsil tissues. 14 The best defining marker for human and mouse Tfh cells is CXCR5. 15, 16 Naive CD4 1 T cells do not express CXCR5 and use CC receptor 7 (CCR7) to enter secondary lymphoid organs and migrate into the T-cell zones. CXCR5 expression is then upregulated in CD4 1 T cells following activation. This upregulation is dependent on costimulatory signals delivered by CD28, ICOS and OX40. 11, [17] [18] [19] However, CXCR5 expression by Th1 and Th2 cells is transient, so most fully differentiated Th cells do not express this receptor (Figure 2) . A fraction of Th cells maintains CXCR5 expression and differentiates into Tfh cells, homes to the B-cell follicles, and provides help to B cells. In addition to sustained CXCR5 expression, downregulation of CCR7 may facilitate the migration of Tfh cells from the T-cell zones into the CXCL13-rich B-cell follicles. 20, 21 Therefore, Tfh cells have been solely defined by their chemotaxis, dictated by CXCR5 expression, while their development is poorly characterized.
It has been suspected that a subset of Th1 and Th2 cells can function as Tfh cells, rather than Tfh cells stemming from a specialized lineage for follicular helper function. However, gene expression analysis of human Tfh cells (CD57 1 CXCR5 hi ) revealed a unique expression profile that is distinct from that of Th1 and Th2 cells. 22, 23 This finding was further supported by the notion that in vivo generated mouse Tfh cells do not express Th1-, Th2-and Th17-specific genes. 24 More importantly, the generation of CXCR5
1 Tfh cells is independent of that of other Th cell lineages (Th1 (IFN-c, STAT1 ), Th2 (IL-4, STAT4), Th17 (IL-17, IL-17F, RORa and RORc) and Treg (TGF-b)), suggesting that Tfh cells represent a distinct lineage. 24 Genetic analysis further identified molecules highly expressed by both mouse and human Tfh cells: ICOS, CD40L, programmed death-1 (PD-1), B-and T-lymphocyte attenuator, signaling lymphocytic activation molecule (SLAM)-associated protein (SAP), IL-6R, IL-21R and Bcl6. 6, 23, 24 Higher expression of these molecules was reported as necessary to both the development and maintenance of Tfh cells and their ability to provide help to B cells.
For years, it was unclear whether Bcl6 was the master transcriptional regulator of Tfh cells. Recently, three groups including our own independently demonstrated that mice lacking Bcl6 are impaired in germinal-center formation and Tfh cell development. [25] [26] [27] These studies indicated that Bcl6 is necessary and sufficient for Tfh cell development. It was also posited that Bcl6 regulates Tfh cell differentiation by repressing alternative differentiation pathways, such as those of Th1-, Th2-and Th17-cell lineages. Taken together, these findings clearly identify Tfh cells as a distinct lineage of Th cells, with Bcl6 as a master regulator of their differentiation.
DIFFERENTIATION OF TFH CELLS
Naive T-cell activation and functional differentiation is triggered by the innate immune system. In response to pathogens, dendritic cells (DCs) upregulate costimulatory molecules to help prime antigenspecific T cells. In addition, APCs also secrete multiple cytokines that regulate T-cell terminal differentiation into effector T cells. Recent studies have established critical roles for costimulatory molecules and certain cytokines in Tfh cell differentiation (Figure 2 ). Costimulation T-cell activation is regulated by costimulatory molecules. CD28, which is expressed on naive T cells, is the most important costimulatory receptor involved in T-cell activation. 28 In the absence of CD28 or its ligands CD80 and CD86, Th cell differentiation into all lineages was found significantly reduced. CD28 costimulation is also essential to Tfh cell development, so CD28-deficient mice are linked with failed upregulation of CXCR5 and OX40 on T cells and disrupted germinalcenter formation. 17 However, CD28-mediated responses, the generation of Tfh cells and germinal-center formation become independent of CD28 and dependent on ICOS when the E3 ubiquitin ligase Roquin is mutated. 29 ICOS belongs to the CD28 family and is expressed on activated T cells. 30, 31 while its ligand, B7h, is broadly expressed on APCs in nonlymphoid tissues. 32, 33 The ICOS-B7h interaction is necessary for optimal T-cell activation as well as for certain effector functions, such as IL-4 and IL-17 expression. [34] [35] [36] [37] [38] In addition, ICOS plays an important role in the regulation of T cell-dependent antibody responses and germinal-center reactions. Mice deficient in ICOS or B7h exhibit impaired germinal-center formation and isotype switching. [34] [35] [36] [37] 39 Recently, this costimulatory pathway was also found to be important for the generation and maintenance of CXCR5 1 Tfh cells. More specifically, ICOS-deficient mice showed impaired development of CXCR5
1 Tfh cells in response to primary or secondary immunization with sheep red blood cells. 6 Meanwhile, ablation of B7h on APCs resulted in decreased expression of IL-21 by T cells. 24 It has also been shown that ICOS is highly expressed by human tonsillar CXCR5 1 T cells within the light zone of germinal centers and efficiently supports immunoglobulin production. 40, 41 Additionally, ICOS deficiency in humans and mice resulted in substantially reduced numbers of Tfh cells and profound defects in B-cell maturation and immunoglobulin isotype switching, indicating an essential role for ICOS in the differentiation of Tfh cells. 11, 19 Interestingly, a mutation in the RING-type E3 ubiquitin ligase Roquin in mice provoked spontaneous germinalcenter formation and enhanced autoantibody production, which is associated with greatly increased numbers of Tfh cells and enhanced IL-21 and ICOS expression. 13 Since B7h is constitutively expressed on B cells, we examined whether Tfh cell generation required cognate B-T-cell interaction. 24 Analysis of a conditional knockout mouse deficient in B-cell expression of B7h revealed that the absence of ICOS ligand from B cells leads to a greatly reduced Tfh cell frequency. In addition to lower CXCR5 expression, we found that IL-21 expression by T cells was greatly reduced in these mice. The ICOS-B7h interaction may thus regulate Tfh cells via production of IL-21. We also observed that antigenspecific IgG production and Peanut agglutinin (PNA) 1 germinalcenter B cells were greatly reduced in the absence of B7h expression on B cells. Our data thus indicate that B7h expression on B cells is necessary for the generation of CXCR5
1 Tfh cells, as well as for IL-21 production and appropriate antibody responses, suggesting an important in vivo function for B cells in the generation or maintenance of Tfh cells.
All of the above observations suggest that defects in Tfh cell development and germinal-center formation in ICOS-deficient mice and patients may be due in part to defective IL-21 production, which usually acts as an autocrine factor that expands the Tfh cell population. In fact, Tfh cell numbers were reduced in IL-21-deficient mice. A recent study presented evidence that ICOS promotes Tfh cell formation through upregulation of c-Maf expression, which enhanced IL-21 expression in a dose-dependent manner. 42 Thus, ICOS-induced c-Maf expression may support Tfh cell formation and maintenance via production of the autocrine growth factor IL-21.
SAP is expressed in T cells and mediates responses to members of the SLAM family by binding to a conserved domain on those receptors. The SLAM family of receptors consists of seven members: CD150/SLAM, CD48/SLAMF2, CD229/Ly9/SLAMF3, CD224/2B4/ SLAMF4, CD84/SLAMF5, NTB-A/Ly108/SLAMF6 and CD319/ CRACC/SLAMF7. Mutation of SAP in humans, as well as studies involving SAP-deficient mice, suggested a critical role for SAP in Bcell help and class switching in Th cells. 43 Of note, SAP-deficient T cells exhibited delayed and decreased ICOS expression but elevated and prolonged CD40L expression. 44 SAP-deficient CD4 1 T cells also fail to stably interact with cognate B cells, therefore failing to induce B-cell clonal expansion. 45 However, these deficient T cells still express normal levels of CXCR5. SAP thus plays a key role in Tfh cell-mediated formation of germinal centers after encountering a cognate B cell, rather than regulating the Tfh cells' migration.
CD84/SLAMF5 and Ly108/SLAMF6 are highly expressed in human and mouse Tfh cells. 46, 47 Using CD84-deficient mice, Cannons et al. showed that CD84 is required for germinal-center formation and Tfh cell differentiation in vivo in a T cell-intrinsic manner. 47 Therefore, the CD84-SAP axis is likely the canonical pathway in CD4
1 T cells that mediates Tfh cell development and function. 1 T cells and natural killer T cells. 49 Previously, it was also reported that IL-21 is expressed at higher levels by Th2 than by Th1 cells. 50 In the latter case, the addition of IL-21 during differentiation decreases IFN-c production by repressing Eomes expression. 51 It has also been observed that IL-21 is induced by IL-6 by means of STAT3, and in combination with TGF-b, is necessary and sufficient for the generation of Th17 cells via STAT3-dependent upregulation of RORc. [52] [53] [54] Both IL-21-and IL-21R-deficient mice are defective in Th17 cell development, suggesting that IL-21 acts in an autocrine fashion, just as IFN-c does for Th1 cells and IL-4 does for Th2 cells.
Additionally, germinal-center development is impaired in IL-21-and IL-21R-deficient mice. 12 In this context, as higher producers of IL-21 than the Th1, Th2 and Th17 subsets, Tfh cells have a beneficial impact on antibody class switch and germinal-center formation. Two groups have recently highlighted the role of IL-21 in the generation of Tfh cells and germinal-center B cells. 24, 55 Immunization of IL-21-deficient mice with a T-cell-dependent antigen resulted in a dramatic reduction in CD4 1 CXCR5 1 T cells, suggesting that IL-21 acts as an autocrine fashion during Tfh cell development. 24 In addition to Tfh cells, significantly lowered numbers of germinal-center B cells and reduced IgG1 production were observed in immunized IL-21-deficient mice. Vogelzang et al. demonstrated that those defects were T-cell, rather than B-cell intrinsic. 55 It has been shown that IL-21 is induced by IL-6 in a STAT3-dependent manner. 24 However, unlike Th17 cells, Tfh cell generation was independent of TGF-b or the Th17-specific orphan nuclear receptors RORa and RORc. 24 Moreover, we have shown that IL-21-producing Th cells can be generated in vitro in the presence of IL-21 but not TGF-b, and that these cells acquire the Tfh gene-expression profile. 24 Transfer of these in vitro generated, IL-21-producing Tfhlike cells into naive mice facilitated B-cell function, similar to Tfh cells. Type I IFNs. Type I IFNs represent a family of cytokines with antiviral and immunomodulatory functions. 57 Multiple subtypes of IFN-a and a single IFN-b subtype are rapidly induced in response to infection and signal through a common IFN-a receptor. 57 These IFNs have been shown to potently enhance the primary antibody response to a soluble protein antigen, augmenting the production of all subclasses of IgG. 58, 59 Additionally, type I IFNs promoted antibody responses when wild-type DCs were transferred to IFN-a receptor-deficient mice, A recent study revealed that type I-IFN signaling in DCs selectively stimulates Tfh cell development in response to antigen bound to Tolllike receptor 3 or 4 agonists. 60 Moreover, DC production of IL-6 is required for in vivo Tfh cell generation and antibody affinity maturation. Thus, type I IFNs enhance T cell-dependent antibody responses by serving as a natural adjuvant for the generation of lymph noderesident CXCR5
1 Tfh cells. It remains to be determined what DC subset regulates the generation of Tfh cells.
Patients with systemic lupus erythematosus (SLE) have increased IFN-a levels, which correlates with disease severity. 61 In addition, studies in various lupus-prone mouse strains have revealed the critical role of type I IFNs in lupus-like pathology. [62] [63] [64] An increased number of Tfh cells has also been observed in mouse models of SLE, 6 ,65 where they are required for lupus-like pathology. 66 However, type I IFNdependent generation of Tfh cells during an autoimmune response has not yet been addressed and requires further investigation.
Transcription factors
The differentiation of naive CD4
1 T cells into different lineages is determined by cytokine signaling and subsequent activation of specific transcription factors (Figure 1 ). For example, IFN-c/IL-12 signaling via STAT1/STAT4 regulates T-bet transcription in Th1 cells, 67 while IL-4 signaling through STAT6 activates GATA3 expression in Th2 cells. 68 IL-6 and IL-21 both act via STAT3, leading to upregulation of the expression of the two Th17-specific orphan nuclear receptors RORc and RORa, which ultimately determine Th17-cell terminal differentiation. 3 For Tfh cell differentiation it has been shown that neither Th1-specific (STAT4, T-bet) nor Th2-selective (STAT6, GATA3) transcription factors are required. 24 Despite the fact that both Th17 and Tfh lineages require IL-6/IL-21 and STAT3, Tfh cell development does not require Th17-related transcription factors (RORa and RORc). Rather, Bcl6 is the master transcriptional regulator of Tfh cell differentiation.
STAT3. IL-21 has been reported to be necessary for Tfh cell differentiation 24 and is induced in T cells by IL-6 in a STAT3-dependent manner. 52 To determine whether STAT3 signaling is required for Tfh cell development, Nurieva et al. analyzed Tfh cell generation in Stat3f/f mice crossed with CD4-cre mice. 24 Immunization of these mice with keyhole limpet hemocyanin in complete Freund's adjuvant revealed a great reduction in CXCR5
1 Tfh cells in the absence of STAT3. Moreover, STAT3 deficiency in T cells led to defective germinal-center B-cell generation and reduced production of keyhole limpet hemocyanin-specific IgG and IgM. Thus, STAT3 plays an important role in Tfh cell differentiation.
Bcl6. The transcription factor Bcl6 is selectively expressed by mouse and human Tfh cells. 69, 70 It was previously shown to inhibit Th2 responses by blocking STAT6 binding to DNA, 71, 72 while Bcl6-deficient mice exhibit multi-organ inflammatory diseases, enhanced IgE production, and defective germinal-center reactions. 71, 73 However, it was unclear whether the germinal-center defect in these mice was caused by a lack of proper T-and/or B-cell function since germinal-center B cells also express Bcl6. 74 Recently, our group and others showed that the transcription factor Bcl6 is a master regulator of Tfh cell differentiation. [25] [26] [27] Bcl6 expression is induced by IL-6 and IL-21 and overexpression of Bcl6 promotes Tfh cell development in the absence of exogenous cytokines. 25 Bcl6 overexpression also leads to increased expression of endogenous Bcl6 mRNA as well as IL-21R, IL-6R and CXCR5 mRNA, as is the case in cells treated with IL-6 or IL-21. Interestingly, IL-21 expression was not upregulated by Bcl6 overexpression. Bcl6 expression also was not required for the development of Th1, Th2 or Th17 cells, and in fact, Bcl6 overexpression repressed the production of Th1, Th2 and Th17 cytokines. 25 Bcl6 function appears to be dependent on DNA binding. 25, 26 It binds to the promoters of the transcriptional regulators T-bet and RORct, which determine Th1-and Th17-cell fate, respectively, resulting in repression of IFN-c and IL-17 production. 26 Furthermore, Bcl6 suppresses expression of microRNAs that are thought to inhibit the Tfh cell signature, including miR-17-92, which represses CXCR5 expression. Thus, Bcl6 regulates Tfh cell development via repression of Th1-, Th2-and Th17-specific transcription factors. Bcl6 deficiency in T cells resulted in impaired Tfh cell development both in vitro and in vivo, and deficiency in both B and T cells is required for germinalcenter reactions. 25, 26, 28 Taken together, these results demonstrate that Bcl6 is both necessary and sufficient for Tfh cell development and provide further evidence supporting the idea that Tfh cells are a distinct lineage of Th cells.
c-Maf. c-Maf was the first transcription factor identified to be preferentially expressed in Th2 cells. 75 It binds to the IL-4 proximal promoter 75 and serves as a Th2-specific factor. T cells deficient in c-Maf were impaired in IL-4 expression during the effector phase, while the expression of other Th2 cytokines was either moderately reduced or unaffected. 76 Previously, using ICOS-and B7h-deficient mice, Dong et al. described mechanisms by which ICOS mediates IL-4 production by regulating c-Maf expression in effector Th cells. 36, 77 Along these lines, the phenotype of c-Maf knockout mice is similar to that of ICOS-deficient mice. Moreover, c-Maf overexpression restores IL-4 release by T cells activated in the absence of the ICOS-B7h interaction. In addition to defective IL-4 production, ICOS-and B7h-deficient mice are impaired in Tfh cell generation and IL-21 production. 24 Kuchroo et al. recently demonstrated that Tfh cells are characterized by high c-Maf expression and that c-Maf enhanced IL-21 levels in a dose-dependent manner. 42 Meanwhile, deletion of c-Maf led to a reduced number of IL-21-expressing Tfh cells. 42 ICOS thus regulates the differentiation of IL-21-producing Tfh cells via upregulation of c-Maf expression.
IFN regulatory factor 4 (IRF4). IRF4 was originally described as a Th2-specific transcription factor, 78, 79 in part since IRF4-deficient mice show significantly reduced levels of serum immunoglobulin. 80 However, recent studies revealed that this transcription factor is induced by IL-1 signaling and is necessary for Th17-cell differentiation. 81 ,82 IRF4-deficient T cells, on the other hand, fail to induce the Th17 lineage upon IL-21 and TGF-b stimulation. 83 Moreover, T cells lacking IRF4-binding protein, a natural antagonist of IRF4, exhibit elevated IL-21 production. 84 IRF4 is thus critical for the production of IL-21 as well as for IL-21-mediated Th cell differentiation.
Given these findings, it seems that IRF4 may also play a role in Tfh cell differentiation. Indeed, IRF4-deficient mice generate fewer CXCR5
1 ICOS 1 Tfh cells upon immunization, 85 indicating the importance of IRF4 during in vivo Tfh cell differentiation. It remains to be determined whether IRF4-dependent Tfh cell generation is T-cell intrinsic and whether IRF4 regulates Bcl6 and B lymphocyte-induced maturation protein-1 (Blimp-1) during Tfh lineage development.
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Negative regulation. Tfh cell differentiation is regulated by a program that antagonizes the development of other Th lineages by suppressing lineage-specific transcription factors (T-bet, GATA3 and RORc). However, it has not been reported whether these factors also negatively regulate Tfh cell differentiation. Blimp-1, which was previously described as antagonizing Bcl6 in B cells, 86 is significantly reduced in Tfh cells as compared with non-Tfh CD4 1 T cells. 27 Overexpression of Blimp-1 in CD4
1 T cells thus prevents Bcl6 expression and significantly reduces the differentiation of Tfh cells, without affecting Th2-, Th17-and Treg-cell development. Moreover, Blimp-1-deficient CD4
1 T cells showed enhanced differentiation into the Tfh lineage. 27 87 Additionally, some IFN-c-producing Tfh cells were observed in the germinal centers after Leishmania infection. 87 Using the Nippostrongylus brasiliensis infection model, this group also showed that IL-4-secreting Tfh cells are distinct from conventional Th2 cells on the basis of phenotype, location and function. By contrast, some have suggested that Tfh cells can differentiate from the Th2-cell lineage and that this process is germinal center-dependent. 88 Consistent with this hypothesis, after helminth infection the lymphoid organs of IL-4 reporter mice contain an IL-4-expressing Tfh population, which displays Tfh markers (IL-21, Bcl6, CXCR5, PD-1 and ICOS) as well as Th2 markers (GATA3). 88 In addition to evidence supporting the existence of a Tfh cell population expressing IL-4 and IFN-c, several studies have shown that during autoimmune disease, CD4
TFH CELLS AND OTHER TH SUBSETS
1 T cells with such Tfh markers as CXCR5 and ICOS are able to express IL-17. 8, 42, 89 This cytokine accelerated germinal-center formation and antibody production. These studies suggest that Tfh cells can produce Th1-, Th2-and Th17-associated cytokines and are potentially derived from these lineages. 
TFH CELLS IN THE PATHOGENESIS OF AUTOIMMUNE DISEASES
Production of high-affinity pathogenic antibodies appears to be central to most autoimmune disorders. Because normal high-affinity antibodies arise from the germinal centers, aberrant selection of germinal-center B cells, caused by either failed negative selection or enhanced positive selection by Tfh cells, results in the production of autoantibodies that cause autoimmunity. Indeed, the correlation between an increased number of Tfh cells and autoimmunity has been described in a lupus model, suggesting that aberrant Tfh cell expansion can lead to the formation of autoantibodies and a lupus-like phenotype. 13, 91 Mice homologous for the sanroque allele of Roquin, which encodes the RING-type ubiquitin ligase, develop a lupus-like disease accompanied by spontaneous development of germinal centers and an excessive number of Tfh cells. 13, 66 Dysregulation of germinal-center responses, leading to autoimmunity, in Roquin san/san mice was caused by excessive Tfh cell differentiation. Loss of one allele of Bcl6, the master transcriptional regulator of Tfh cells, significantly reduced the number of germinal-center cells and minimized the lupus phenotype. 66 In addition, SAP deficiency in Roquin san/san mice abrogated spontaneous Tfh cell and germinal-center formation and reduced renal pathology. 66 By contrast, adoptive transfer of Tfh cells from Roquin san/san mice into wild-type recipient mice led to spontaneous germinal-center formation. Interestingly, excessive Tfh cell generation and lupus pathogenesis in this model may be more dependent on ICOS than on IL-21. Using the New Zealand black/New Zealand white mouse model of SLE, Hu et al. demonstrated that blockade of ICOS-B7h signaling leads to decreased numbers of Tfh cells and germinal-center B cells and inhibition of autoimmunity. 92 There is evidence that patients with SLE have increased numbers of circulating CXCR5
1 ICOS hi PD-1 hi CD4 1 T cells in the peripheral blood, as compared to non-autoimmune individuals. 93, 94 This cell population was correlated with disease severity, indicated by higher titers of antidouble-stranded DNA antibodies and more severe kidney damage. Thus, as in Roquin san/san mice, dysregulation of Tfh cell formation may contribute to autoimmune pathology in SLE patients.
Overexpression of Tfh-specific cytokines has been shown to cause autoimmunity. Previous work has demonstrated that BXSB-Yaa mice, a model of SLE, have elevated IL-21 DNA and serum protein levels, which correlates with more severe disease. 95 Similarly, human studies suggest that allelic variation in the IL-21 gene is a risk factor for SLE. 96 To determine whether IL-21 plays a significant role in the pathogenesis of this disease, Bubier et al. compared IL-21R-deficient and IL-21R-competent BXCB-Yaa mice for multiple parameters of SLE-like autoimmune disease. 97 IL-21 signaling appeared to be significant for the development of an SLE phenotype, as IL-21R-deficient mice lacked such SLE symptoms as autoantibody production and renal disease. Interestingly, in this model, the germinal-center Tfh cells and extrafollicular population of ICOS 1 CD4 1 T cells produced IL-21. In the 98 Thus, pathogenic IL-21 secretion is not restricted to germinal-center Tfh cells, but can also occur outside of the follicles. The IL-21 signaling pathway is therefore a promising target in the development of immunotherapy against both Tfh-and Th17-mediated disorders.
CONCLUDING REMARKS
Great advances in our understanding of Tfh cell differentiation and involvement in immune responses have been made over the past few years. However, the signaling events required for commitment of CD4
1 Th cells to the Tfh subset are only beginning to be elucidated. Expression of IL-21 and Bcl6 is absolutely required for Tfh cell generation in both mice and humans, although the precise mechanisms controlling the expression of these major Tfh factors have yet to be resolved. Additionally, the relationship of Tfh cells to other Th lineages needs to be further characterized. Future identification and analysis of new signaling components required for Tfh cell generation using both traditional and new technologies, such as gene knockout and small interfering RNA-based gene knockdown, may advance our knowledge of Tfh cell biology in health and disease. These technologies may also provide a novel strategy for developing therapeutic agents that selectively modulate Tfh cell function to treat autoimmunity.
